How Do Decarboxylase Inhibitors Work?

Reviewed on1/12/2022

HOW DO DECARBOXYLASE INHIBITORS WORK?

Decarboxylase inhibitors are a class of medications used to treat symptoms of Parkinson’sdisease.

The direct cause of Parkinson's disease or Parkinsonian-likesyndromeis the deficiency of theneurotransmitterdopamineinthebrain. Antiparkinson medications aim to prolong the action of dopamine in the brain by:

  • Replacing dopamine
  • Inhibiting dopamine breakdown
  • Sensitizing dopamine receptors to stimulate dopamine release

Decarboxylase is anenzymethat initiates the breakdown of levodopa after exerting its effect. Decarboxylase inhibitors block the action of decarboxylase, thereby preventing the breakdown of levodopa, which in turn, increases the availability of levodopa at theblood-brain barrier, thus allowing a lower dose of levodopa. Levodopa gets converted into dopamine in the brain and restores the depleted dopamine levels.

HOW ARE DECARBOXYLASE INHIBITORS USED?

Decarboxylase inhibitors can be used alone or as a combination with other drugs to treat Parkinson's disease and its symptoms.

WHAT ARE SIDE EFFECTS OF DECARBOXYLASE INHIBITORS?

Some of the side effects of decarboxylase inhibitors include:

The information contained herein is not intended to cover all possible side effects, precautions, warnings, drug interactions, allergic reactions, or adverse effects. Check with yourdoctoror药剂师to make sure these drugs do not cause any harm when you take them along with other medicines. Never stop taking yourmedicationand never change your dose or frequency without consulting your doctor.

WHAT ARE NAMES OF DECARBOXYLASE INHIBITORS?

Genericand brand names of decarboxylase inhibitors include:

References
https://reference.medscape.com/drugs/decarboxylase-inhibitors

Health SolutionsFrom Our Sponsors